MME and congestive heart failure: Neprilysin inhibitors (NEPI) can influence the metabolism of multiple peptides; previous studies have confirmed that inhibiting NEP can elevate the concentration of these peptides, improving the therapeutic effects for patients with chronic heart failure (Bayes-Genis et al., 2016).